Biotech/Pharma Companies Targeting Pancreatic Cancer: (SBFM), (NLNK), (LLY), (CELG)

Point Roberts WA, New York, NY - February 19, 2014 (Investorideas.com Biotech Newswire) Investorideas.com global news source covering leading sectors including biotech and pharma reports on companies in the sector targeting pancreatic cancer. Stocks mentioned include NewLink Genetics (NLNK), Sunshine Biopharma Inc. ( OTCBB: SBFM ), Eli Lilly and Company (NYSE:LLY) and Celgene (NASDAQ:CELG).

Decision Resources ( http://www.decisionresources.com/ ),one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the pancreatic cancer therapy market will nearly double to $1.3 billion in 2022, owing to the launch and rapid uptake of three high-priced agents-Celgene (NASDAQ:CELG)/Taiho's Abraxane, Onconova Therapeutics/Baxter International/SymBio Pharmaceuticals' Estybon and Merrimack Pharmaceuticals' MM-398 (a novel formulation of irinotecan). Even though these agents do not substantially improve the overall survival of pancreatic cancer patients, they will have a significant impact on current treatment.
The Pharmacor Pancreatic Cancer report also finds that significant commercial reward awaits developers of therapies that are more effective and better tolerated than the FOLFIRINOX regimen in this disease, as the need for efficacious, well-tolerated therapies will remain through 2022.
NewLink Genetics (NASDAQ:NLNK) has been of the top gainers for 2014,gaining over 90%.NewLink's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a wide range of oncology indications.
Their product, RAlgenpantucel-L is an investigational HyperAcute™ immunotherapy for pancreatic cancer. The product consists of 2 pancreatic cancer cell lines (HAPa-1 and HAPa-2) that have been genetically modified to express alpha-gal carbohydrates on cell surface molecules.1 Upon injection into the patient, the alpha-gal stimulates an immune response against pancreatic cancer-specific antigens in the tumor cell lines. The patient’s immune system then targets its own pancreatic cancer cells, destroying them.1 In the adjuvant setting, the immune response targets and eradicates residual tumor cells in conjunction with chemotherapy and chemoradiation.1,2.
Algenpantucel-L is currently being studied in combination with standard of care in two phase 3 trials:
Last fall the company reported greater than expected responses to follow-on chemotherapy after treatment with algenpantucel-L or tergenpumatucel-L HyperAcute immunotherapy. Three pancreatic cancer patients were followed for response to subsequent salvage chemotherapy treatment after progressing on algenpantucel-L therapy. All three patients experienced durable (12-36 months), complete responses.
Sunshine Biopharma Inc. ( OTCBB:SBFM ), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, recently announced that it is targeting pancreatic cancer as second indication for its leading compound, Adva-27a.
As previously announced, Adva-27a was found to be effective at killing Pancreatic Cancer Cells in vitro. Based on initial data, the company is now advancing research using Adva-27a for pancreatic cancer treatment.
The initial study, as reported in June 2013, was carried out in the very aggressive Pancreatic Cancer cell line, Panc-1. Adva-27a was able to kill these cells with an IC50 of less than 4 micromolar, a pharmacologically very favorable drug concentration.
Adva-27a is Sunshine Biopharma's lead anticancer compound, a small molecule that has recently been shown to be effective at killing multidrug resistant breast cancer cells, small-cell lung cancer cells, uterine sarcoma cells and pancreatic cancer cells (Published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012). Adva-27a is currently in the IND-Enabling stage of development. The original U.S. patent covering Adva-27a was issued on August 7, 2012 under US patent number 8,236,935.
According to Global Industry Analysts, Inc. in their recent report, "Eli Lilly's (NYSE:LLY) Gemzar (Gemcitabine) is the current gold standard of care for locally advanced and metastatic disease, with a dominance that is undisputed despite a median survival of less than 6 months and rate of one-year survival of around 18%, as stated by the new market research report on Pancreatic cancer drugs. Though the odds of survival are somewhat better in other forms of cancer, the rate of five-year survival for the most common form of pancreatic cancer, Adenocarcinoma of the pancreas is less than 5%, with majority of patients surviving just a few months. "
www.Investorideas.com - Big ideas for Global Investors
Investorideas.com is a global news source and resource base for investors following tech stocks, biometric stocks, water stocks, biotech stocks, energy stocks, mining stocks, renewable energy stocks, nanotech and Latin American stocks.
Follow Investorideas.com on Twitter  
Follow Investorideas.com on Facebook  
Follow Investorideas.com News on Linkedin.com/today
Sign up for free news alerts and get free research tools:
http://www.investorideas.com/Resources/Newsletter.asp
Join us and become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in leading sectors
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investor ideas is protected by copyright laws other than syndication rights. Investor ideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure investor ideas has been compensated with 144 shares for news and content publication ( 100,000 per three month period)
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
800-665-0411 -   Source – www.Investorideas.com

Mining Stock Alert: SilverCrest (TSX.V: SVL) (NYSE MKT: SVLC) Confirms U/G High Grades at Santa Elena 11.6m @ 5.83 gpt Au and 232.5 gpt Ag including 1.15m @ 21.7 gpt Au and 572 gpt Ag

Vancouver, British Columbia - February 17, 2014 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX.V:SVL) ( NYSE MKT: SVLC) is pleased to announce results of further delineation underground drilling completed in Q4, 2013 at the Santa Elena Mine in Sonora, Mexico. Twenty two closely-spaced (est. 25 metres) underground drill holes, totaling 1,590 metres have been completed to better define underground resources and verify widths and grades for the first planned production stopes to be mined in 2014 (see table below and attached Figure). The results of all holes included in this news release will be part of a resource update scheduled to be completed in H2 2014.

N. Eric Fier, CPG, P.Eng., President & COO stated; “This underground drill program was successful in confirming good continuity of the Main Mineralized Zone (MMZ) and high grades for the initial planned production stopes to be mined in 2014. Valuable information was also provided from this program to better define overall reserves and subsequent stope designs. We look forward to successfully transitioning from our current open pit heap leach operation to underground mining with a 3000 tonnes per day conventional mill by H2 2014.”
The drill program, with estimated 25 metre centres, confirmed the consistent continuity and geometry of the MMZ. Drill result reconciliation with previous wider-spaced (est. 50 metres) drilling in this area showed comparable widths and grades.
he most significant assay results from this underground drilling program are shown in the following table and interval widths are considered near-true thickness.
All sample analyses were completed by ALS Chemex in Hermosillo, Mexico and North Vancouver, BC.
Core hole SEUG-13-12 was abandoned before intersecting mineralization.
As Santa Elena progresses into an underground operation further delineation drilling will be completed in 2014 to continue to verify production stope reserves. As of January 31, 2014, approximately 2,730 meters of underground lateral development including ramp access, 675 metres of ore development, and 430 metres of raise development had been completed by an independent contractor. Approximately 35,000 tonnes of ore from underground development has been delivered to the leach pad for partial metal recoveries by leaching and will be reprocessed through the nearly completed CCD/Merrill Crowe mill. With the arrival of the Company’s underground production equipment in May 2014, test stoping is scheduled for late Q2 and early Q3 2014.
The Qualified Person under NI 43-101 for this News Release is N. Eric Fier, CPG, P.Eng, and Chief Operating Officer for SilverCrest Mines Inc., who has reviewed and approved its contents.
SilverCrest Mines Inc. (TSX VENTURE:SVL)(NYSE MKT:SVLC)(NYSE Amex:SVLC) is a Canadian precious metals producer headquartered in Vancouver, BC. SilverCrest’s flagship property is the 100%-owned Santa Elena Mine, located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, México. The mine is a high-grade, epithermal silver and gold producer, with an estimated life of mine of 8 years and cash costs of $11 per ounce of silver equivalent (55:1 Ag:Au) for the open pit heap leach and underground mine. SilverCrest anticipates that the new 3,000 tonnes per day conventional mill facility at the Santa Elena Mine should recover an average annual rate of 1.5 million ounces of silver and 32,800 ounces of gold over the current reserve. Major expansion and construction of the 3,000 tonnes per day conventional mill facility is nearing completion and is expected to significantly increase metals production at the Santa Elena Mine (open pit and underground) in 2014 and beyond. Exploration programs continue to make new discoveries at Santa Elena and also have rapidly advanced the definition of a large polymetallic deposit at the La Joya property in Durango State with stated resources nearing 200 million ounces of Ag equivalent.
FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of Canadian securities legislation and the United States Securities Litigation Reform Act of 1995. Such forward-looking statements concern the Company's anticipated results and developments in the Company's operations in future periods, planned exploration and development of its properties, plans related to its business and other matters that may occur in the future. These statements relate to analyses and other information that are based on expectations of future performance, including silver and gold production and planned work programs. Statements concerning reserves and mineral resource estimates may also constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if the property is developed and, in the case of mineral reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation: risks related to precious and base metal price fluctuations; risks related to fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and United States dollar); risks related to the inherently dangerous activity of mining, including conditions or events beyond our control, and operating or technical difficulties in mineral exploration, development and mining activities; uncertainty in the Company's ability to raise financing and fund the exploration and development of its mineral properties; uncertainty as to actual capital costs, operating costs, production and economic returns, and uncertainty that development activities will result in profitable mining operations; risks related to reserves and mineral resource figures being estimates based on interpretations and assumptions which may result in less mineral production under actual conditions than is currently estimated and to diminishing quantities or grades of mineral reserves as properties are mined; risks related to governmental regulations and obtaining necessary licenses and permits; risks related to the business being subject to environmental laws and regulations which may increase costs of doing business and restrict our operations; risks related to mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to inadequate insurance or inability to obtain insurance; risks related to potential litigation; risks related to the global economy; risks related to the Company's status as a foreign private issuer in the United States; risks related to all of the Company's properties being located in Mexico and El Salvador, including political, economic, social and regulatory instability; and risks related to officers and directors becoming associated with other natural resource companies which may give rise to conflicts of interests. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements. The Company's forward-looking statements are based on beliefs, expectations and opinions of management on the date the statements are made. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
The information provided in this news release is not intended to be a comprehensive review of all matters and developments concerning the Company. It should be read in conjunction with all other disclosure documents of the Company. The information contained herein is not a substitute for detailed investigation or analysis. No securities commission or regulatory authority has reviewed the accuracy or adequacy of the information presented
N. Eric Fier, President and COO
SILVERCREST MINES INC.
Neither TSX Venture Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
SilverCrest Mines Inc.
Fred Cooper
(604) 694-1730 ext. 108 or Toll Free: 1-866-691-1730
(604) 694-1761
info@silvercrestmines.com
www.silvercrestmines.com
Published at Investorideas.com Newswire
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: SilverCrest Mines has compensated Investorideas.com for the distribution and publishing of this news release (annual news publication 9700) http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Investorideas.com Security Conference Features Leading Thought Leaders in Biometrics and Cybersecurity; Adds Janice Kephart, Founder and CEO of Secure Identity and Biometrics Association (SIBA) and Phil Agcaoili, Chairman, Ponemon Institute Fellows, Co-founding Member, Cloud Security Alliance and Board Member, Mobile Active Defense to Speaker List

New York, NY - February 14, 2014 (www.investorideas.com newswire) Investorideas.com, an investor research and news portal covering leading sectors including technology and defense, announces new speakers for its upcoming Security and Defense Conference, “Game Changing Technologies: The Face and Future of Security”, to be held live in New York and online on March 11, 2014. New speakers include Janice Kephart, Founder and CEO of The Secure Identity and Biometrics Association (SIBA) and Phil Agcaoili, Chairman, Ponemon Institute Fellows, Co-founding Member, Cloud Security Alliance and Board Member, Mobile Active Defense.

The theme of the conference will share insight into developments in biodefense, biometrics including fingerprint, voice and facial recognition, cyber security and other security and defense issues. The agenda will include a financial panel, and industry panel and presenting companies showcasing their technologies. The current list of speakers represents some of the top thought leaders in biometrics and cybersecurity including cybersecurity expert and counterterrorism analyst Roger Cressey.
Janice recently returned from a Special Counsel position with the Senate Judiciary Committee, where she was asked to testify and then return to staff to support the national, border and identity security aspects of the now Senate-passed immigration reform legislation. Ms. Kephart is an internationally recognized border and ID security expert, who served as counsel to the 9/11 Commission and was a key author of the Staff Monograph, ‘9/11 and Terrorist Travel’ as well as the immigration and identity/security-related facts and recommendations in the 9/11 Commission Report.
Janice speaks regularly at conferences, to international media, publishes articles and op-eds around the world, and has testified before Congress 16 times on issues of border and ID security. More info: http://www.sibassoc.org/#!aboutsiba/csgz
Phil Agcaoili has been an influential leader in the Information Security industry for over 20 years and has established world class security organizations from startups to the Fortune 25. Phil has led successful security teams at General Electric, VeriSign, Alcatel, Scientific Atlanta, Dell, and Cox Communications and was involved in three consecutive and successful startups. He co-founded SecureIT, which he sold to VeriSign for $70M, and was VeriSign's first Chief Information Security Officer. He was also an early foundation member of Internet Devices, acquired by Alcatel for $181M. He was the Chief Security Architect for Scientific Atlanta which was acquired by Cisco Systems for $6.9B. Phil participated and influenced the development of the NIST Framework for Improving Critical Infrastructure Cybersecurity.
He's shaped Cyber Security for US Telecoms as committee co-chair of the FCC CSRIC and Communications Sector Coordinating Council, and Communications ISAC. He set cloud standards as a founding member of the Cloud Security Alliance (CSA) and is co-founder/author of Cloud Controls Matrix (CCM), Cloud Security Trust, and Assurance Registry (STAR) and Open Certification Framework, aligned security and privacy attestations with the AICPA for SOC 2 attestations (the replacement for SAS 70 attestations), set eDiscovery standards with EDRM, and is a privacy and trust leader as a Ponemon Institute Distinguished Fellow and the Chairman of the Fellows. Phil won the inaugural Information Security Executive of the Decade Award in 2012, 2012 RSA Conference Award for Excellence in the Field of Security Practices, 2010 Information Security Magazine Security 7 Award, and 2009 Information Security Executive of the Year Central Award. Many of Phil’s team leaders have started their own companies or they have gone on to lead other successful global security teams.
The growing list of speakers and presenters includes Kris Tuttle, Director of Research for SoundView Technology Group; cybersecurity expert and counterterrorism analyst Roger Cressey*, Partner with Liberty Group Ventures; and Kiersten Todt**, President and Managing Partner of Liberty Group Ventures.
*From 2004 - 2013, Roger Cressey served as an on-air counterterrorism analyst with NBC News, appearing frequently on NBC Nightly News, The Today Show, MSNBC and CNBC.
**Ms. Todt has commented on homeland security and sport security issues in multiple media outlets, including MSNBC, NPR, Bloomberg, and The Wall Street Journal. Her work on sport security has been published in two editions of The International Centre for Sport Security Journal.
Additional speakers include Marty Martin, CEO of Crane & Crane Consulting, who also has a background with the CIA, NSA, and the U.S. Army; Scott Greiper, President and Founding Partner of Secure Strategy Group; and Scott Sacknoff, President of Spade Defense Index (NYSE: ^DXS) .
Learn more about the conference:
http://www.investorideas.com/Conference
Presenting Companies
See the growing list of companies: http://www.investorideas.com/Conference/Companies.asp

Investorideas.com Security and Defense Conference:

Game Changing Technologies: The Face and Future of Security

Tuesday, March 11, 2014

The New York Hilton Midtown and Online at a unique content and syndication platform

Investors, media and industry service providers: Register here free: http://www.investorideas.com/Conference/Conference-Registration.asp
Presenting Companies: Visit the conference page to learn more and sign up:
http://www.investorideas.com/Conference
Media Partners:
Media partners include www. SecuritySolutionsWatch.com , a breaking News site covering new security solutions and business trends, SecurityStockWatch.com for investors following the sector, www.Wallstreetcalendar.com , informing the institutional investment community, Australian Security Magazine ( http://www.australiansecuritymagazine.com.au/ ) Global Security Finance (www.globalsecurityfinance.com), an online daily news and data service covering the physical, cyber and identity security and defense sectors, Hedge Connection ( https://www.hedgeconnection.com ), an interactive, web-based marketing tool available to hedge funds and investors, and http://www.biometricstechnologywatch.com/ .
About InvestorIdeas.com: www.investorideas.com
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks and Latin American stocks.
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country.
Presenting Companies Contact info:
Cali Van Zant cvanzant@investorideas.com 800. 665. 0411
Sponsorship info:
Eric Salvarezza esalvarezza@investorideas.com 631. 664. 1311
Media Partners:
Dawn V dvanzant@investorideas.com 800. 665. 0411
800-665-0411 - Source: www.Investorideas.com

Biotech News Alert: SUNSHINE BIOPHARMA (OTCQB: SBFM) BEGINS CONSTRUCTION OF MOUSE XENOGRAFT MODELS FOR PANCREATIC CANCER TO ADVANCE Adva-27a AS A TREATMENT FOR THIS DEADLY FORM OF CANCER

Montreal, Quebec, Canada - February 14, 2014 (Investorideas.com Biotech Newswire) Biopharma alert: Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has initiated the construction of mouse xenograft models for pancreatic cancer as part of the plans of positioning Adva-27a for clinical development for pancreatic cancer in parallel with multidrug resistant breast cancer. The work is being conducted in collaboration with Sunshine Biopharma’s parent company, Advanomics Corporation, the co-recipient of $1.45 million in research grants in Canada. As previously announced (see press release dated June 4, 2013), Adva-27a, a Topoisomerase II inhibitor, was found to be effective at destroying cells of the very aggressive pancreatic cancer cell line, Panc-1.

"Conducting tests in pancreatic cancer xenograft models is the next step in our preparations for doing parallel breast cancer and pancreatic cancer clinical trials of Adva-27a," said Dr. Steve N. Slilaty, Chief Executive Officer of Sunshine Biopharma. "Pancreatic cancer is an extremely aggressive form of cancer with essentially no effective treatment options available today. We are heartened by the prospects that Adva-27a could become an effective therapy for patients suffering this deadly form of cancer."
About Pancreatic Cancer
Pancreatic cancer has an extremely poor prognosis. Most pancreatic cancer patients will die within one year of diagnosis. Cancer of the pancreas is the fourth most common cause of cancer-related deaths in the United States. According to the American Cancer Society, an estimated 45,220 new cases of pancreatic cancer will be diagnosed in the U.S. in 2013. Approximately 95% of pancreatic tumors are of the adenocarcinoma type, arising within the exocrine component of the pancreas where various digestive enzymes are produced. The remaining 5% arise from the islet cells and are classified as neuroendocrine tumors. The islet cells produce important hormones such as insulin, which regulates the sugar levels in the blood. Both types are very aggressive and respond poorly to standard chemotherapy drugs. In contrast to the downward trend in death rates for most major cancer types, death rates due to pancreatic cancer have been slowly increasing in the U.S. over the past decade. This, together with the lack effective therapy, underscores the need for major new drug development efforts to reverse these trends.
About Adva-27a
Adva-27a is Sunshine Biopharma's lead anticancer compound, a small molecule that has recently been shown to be effective at killing multidrug resistant breast cancer cells, small-cell lung cancer cells, uterine sarcoma cells and pancreatic cancer cells (Published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012). Adva-27a is currently in the IND-Enabling stage of development. The original U.S. patent covering Adva-27a was issued on August 7, 2012 under U.S. patent number 8,236,935.
About Sunshine Biopharma Inc.
Sunshine Biopharma is an early stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. Sunshine Biopharma recently announced that it has initiated IND-Enabling studies for its lead antitumor compound, Adva-27a, which is currently targeted for multidrug resistant cancer.
Safe Harbor Forward-Looking Statements
To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.
For Additional Information Contact:
Camille Sebaaly, CFO
Sunshine Biopharma Inc.
Direct Line: 514-814-0464
camille.sebaaly@sunshinebiopharma.com
www.sunshinebiopharma.com
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: SBFM has renewed effective December 3,2013 with Investorideas for six months of news publication and general public awareness of the company news and technologies and products in the biopharma markets ( one hundred thousand shares of 144 stock per 3 month period for a total of six months ) More disclaimer info: http://www.investorideas.com/About/Disclaimer.aspBC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Security and Defense Sector Alert: Investorideas.com Conference Adds Biodefense Company PositiveID (OTCQB: PSID) to Presenters: Themes Include Biodefense, Biometrics and Cybersecurity

New York, NY - February 11, 2014 (www.investorideas.com newswire) Investorideas.com, an investor research and news portal covering leading sectors including technology and defense, announces new speakers for its upcoming Security and Defense Conference,” Game Changing Technologies: The Face and Future of Security”, to be held live in New York and online on March 11, 2014.

Added to presenting companies is PositiveID Corporation, (OTCQB: PSID) an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid biological testing.
William J. Caragol, Chairman and CEO of PositiveID (OTCQB:PSID) , said, "We look forward to educating potential investors about our M-BAND and Firefly Dx counter-terrorism and bio-threat detection technologies, which offer solutions to fill a critical need in homeland defense and healthcare."
The theme of the conference is game changing technologies, the face and the future of security, discussing developments in biodefense, biometrics including fingerprint, voice and facial recognition, cyber security and other leading edge technology.
The agenda will include a financial panel, and industry panel and presenting companies showcasing their technologies.
The growing list of speakers and presenters includes Kris Tuttle Director of Research for SoundView Technology Group, cybersecurity expert and counterterrorism analyst Roger Cressey, Partner with Liberty Group Ventures and Kiersten Todt , President and Managing Partner of Liberty Group Ventures. From 2004 - 2013, Roger Cressey served as an on-air counterterrorism analyst with NBC News, appearing frequently on NBC Nightly News, The Today Show, MSNBC and CNBC. Ms. Todt has commented on homeland security and sport security issues in multiple media outlets, including MSNBC, NPR, Bloomberg, and The Wall Street Journal. Her work on sport security has been published in two editions of The International Centre for Sport Security Journal.
Additional speakers include Marty Martin, CEO of Crane & Crane Consulting, who also has a background with the CIA, NSA, and the U.S. Army, Scott Greiper, President and Founding Partner of Secure Strategy Group, Scott Sacknoff, President of Spade Defense Index (NYSE: ^DXS) .
Presenting Companies
PositiveID Corporation (OTCQB: PSID) is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. For more information on PositiveID, please visit http://www.PositiveIDCorp.com
See more companies: http://www.investorideas.com/Conference/Companies.asp
Investorideas.com Security and Defense Conference:
Game Changing Technologies: The Face and Future of Security
Tuesday, March 11, 2014
The New York Hilton Midtown and Online at a unique content and syndication platform
Register here free: http://www.investorideas.com/Conference/Conference-Registration.asp
Presenting Companies: Visit the conference page to learn more and sign up:
http://www.investorideas.com/Conference
Media Partners:
Media partners include www. SecuritySolutionsWatch.com , a breaking News site covering new security solutions and business trends, SecurityStockWatch.com for investors following the sector, www.Wallstreetcalendar.com , informing the institutional investment community, Australian Security Magazine ( http://www.australiansecuritymagazine.com.au/ ) Global Security Finance (www.globalsecurityfinance.com), an online daily news and data service covering the physical, cyber and identity security and defense sectors, Hedge Connection ( https://www.hedgeconnection.com ), an interactive, web-based marketing tool available to hedge funds and investors, and http://www.biometricstechnologywatch.com/ .
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks and Latin American stocks.
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.aspBC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Presenting Companies Contact info:
Cali Van Zant cvanzant@investorideas.com 800. 665. 0411
Sponsorship info:
Eric Salvarezza esalvarezza@investorideas.com 631. 664. 1311
Media Partners:
Dawn V dvanzant@investorideas.com 800. 665. 0411
800-665-0411 - Source: www.Investorideas.com

Q&A Interview with CEO and President of Powerdyne International (OTCBB: PWDY); 2014 Roll-Out of Portable Energy Generation Products

New York, NY, Point Roberts WA - February 11, 2014 (Investorideas.com newswire) Investorideas.com, a global news portal covering leading sectors, issues an exclusive Q&A with the Dale P. Euga, CEO and President of Powerdyne International, Inc. (OTCBB: PWDY), a company that manufactures portable power generation equipment . In a two- part series, Mr. Euga will discuss the 2014 roll- out of their PDIGenset to the portable energy generation market and its potential first commercial sale.

Interview:
Q: Investorideas.com
For readers unfamiliar with your company and hearing about your technology for the first time, can you give us a brief summary of how it works and what the revenue model is based on ?
A: Mr. Dale P. Euga, CEO and President
Our product is a large scale portable electric generator that is powered by a new type of engine. The savings a client receives from using our patent pending technology is approximately a third of their existing power bill. This can be a very significant savings.
The most critical technology we employ is in the engine which produces the operating efficiencies and characteristics. The engine and generator operating together produce electrical power very efficiently at a low operational cost using natural gas as the primary fuel. Unlike other prime movers in the industry, our Powerdyne engine is radial in design, small, powerful, light weight, air cooled, and easily serviced and maintained.
The Powerdyne business model is based on independent electric power generation on the client's site and providing independent base load power to supplement the power that the client draws from the grid. The power generated by the Powerdyne electrical power costs the client less than that drawn from the grid and thereby provides constant base load power at a substantial saving for the client. The difference between what it costs Powerdyne to produce the power, and what the client will pay Powerdyne for that power is the revenue stream for our business.
Q: Investorideas.com
Dale, last November the company announced it would perform an engineering survey for the installation of two of its PDIGensets at Silver City Aluminum Company, Taunton, MA. Can you give us the results and how that went?
A: Mr. Dale P. Euga, CEO and President
The initial study was completed on November 20 th which proposed locating the Powerdyne equipment on the right side of the building near the Nitrogen tanks. This plan was reviewed with the client and the plant engineer. All of the special conditions of the site and the electrical engineering were completed in that study. The difficulties identified in that study were workable. However it was suggested by the plant engineer that it might be more efficient and practical to consider a different location for the equipment. A second on-site meeting with the owner and the plant manager was held on December 5 th and after consideration of the details of that study, it was concluded that a different location would be more practical.
A second engineering study was completed on December 12 th which located the Powerdyne equipment further back toward the right rear of the building. This study incorporated most of the details and construction concerns of the previous study and installation costs were adjusted accordingly. This plan was accepted by the owner and also accepted by the plant engineer on January 6, 2014.
Q: Investorideas.com
If everything goes according to plan what is the potential model/framework of an agreement with a company like this?
A: Mr. Dale P. Euga, CEO and President
We are in the process of negotiating a formal agreement with our first client, Silver City Aluminum Company. We have been composing a memorandum of understanding with the owner which will identify the responsibilities of both parties, parameters of the work, and provide a schedule for production, delivery of equipment and commissioning of the Powerdyne units. This agreement will be also incorporated into the final terms and conditions of the PPA (Power Purchase Agreement). It is anticipated that an agreement could be finalized before the end of January 2014.
Q: Investorideas.com
Have you mapped out a manufacturing plan if you receive commercial orders?
A: Mr. Dale P. Euga, CEO and President
Yes. We have very serious interest from three other domestic businesses and we are prepared to act immediately. With the placement of an order from a qualified client, the PDIGenset can be manufactured, delivered, and commissioned within six months for a domestic client – same for foreign orders. Final delivery and commissioning are subject to foreign import tariffs and customs which are the sole responsibility of the client.
Q: Investorideas.com
What kind of other customers are you targeting and if the deal goes ahead with Silver City Aluminum Company, will it serve as a model for other potential customer?
A: Mr. Dale P. Euga, CEO and President
Target customers are commercial and manufacturing businesses that have a significant and constant electric power base load requirement. These primary target clients include hospitals, cold storage facilities, shopping malls, industrial fabrication, sewage treatment plants, and hotel and resort complexes. In addition, remote areas that are power deficient such as some Caribbean Islands are prime candidates for independent power stations.
Q: Investorideas.com
What are the most significant cost advantages and environmental benefits of your products ?
A: Mr. Dale P. Euga, CEO and President
The customer advantages are threefold. The most significant advantage is that the customer has zero capital outlay from to have the Powerdyne equipment manufactured and installed at his location. Secondly, the client should reap a significant cost savings (about 1/3) on the overall electric utility cost. And lastly, Powerdyne operates and maintains the equipment.

• Investorideas.com will issue a follow up interview as events materialize.

About Powerdyne International, Inc. ( OTCBB: PWDY )
Powerdyne International, Inc. (www.PowerdyneInternational.com) is a manufacturing company that builds and leases electrical generation equipment including its own portable electrical power generation equipment called PDIGenset (which is patent and trademark pending).
PDIGensets are designed to be installed at virtually any location. The genset is leased and maintained by PDI. Although the company's target customer will typically use its PDIGenset to produce its own primary electrical power, however, the genset is useful in any situation where reliable power is needed.
PDI is founded on the ability to produce primary electrical power using proprietary technology to power electrical generation equipment which makes electricity cheaper than existing means of producing primary electric power. PDI expects that the difference between its cost of generating electricity over its customer's current cost will result in substantial savings to the customer. For more information on Powerdyne International go to: www.PowerdyneInternational.com
About www.InvestorIdeas.com :
InvestorIdeas.com is a global news source and resource center covering leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and Latin American stocks.
Sign up for free news alerts: http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com newswire is a recognized news source and publisher of news and research. Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news release submissions, content marketing and online advertising. All investment involves risk. More info: http://www.investorideas.com/About/Disclaimer.aspDisclosure: Investorideas has been compensated by PWDY two thousand for news publication and content publishing for one month. BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors please refer to your regulation regarding trading foreign securities.
800-665-0411 - Source - www.Investorideas.com

NXT-ID (OTCQB: NXTD) Media: "The Housing Hour -The World of Wallets is about to change!"

SHELTON, CT - February 10, 2014 (Investorideas.com Newswire) NXT-ID, Inc. (OTCQB: NXTD), a biometrics company focused on the growing m-commerce market, was recently featured on The Housing Hour, http://www.thehousinghour.com/category/shows/. Mr. David Tunnell, Co-founder and Chief Architect of The Wocket™, discusses in detail how the The Wocket™ is the next generation smart wallet for consumers.

The World of Wallets is about to change!
The Housing Hour
http://www.thehousinghour.com/category/shows/
The Wocket™
Special Guest: David Tunnell, co-founder and chief architect
The world of wallets is about to change. New exciting technologies are making payments easier than ever. However, many credit card holders either do not possess a smartphone or will be reluctant to use their smartphone for mobile payments due to a variety of reasons.
Rather than depend on a potentially unreliable cell phone, NXT-ID introduces a truly next generation digital wallet: The Wocket™. This unique technology takes a very different approach: Instead of replacing the wallet, we are improving it! Our innovative Wocket™ reduces the number of cards in your wallet while supporting virtually every payment method currently available at Point-of-Sale (POS) at retailers around the world including magnetic stripe, EMV/NFC and barcode…all within a secure vault within your wallet.
Now you can use the wallet you know and love, but with The Wocket™ advanced secure electronic wallet technology from NXT-ID.
Recent Media Coverage:
"Retailers Try to Keep Pace With Cybercriminals"
WSJ-Risk & Compliance Journal-Other companies are touting products they say are superior to--and less costly than–pin-and-chip technology. Biometrics company NXT-ID this month announced a checkout technology it said secures payment information before, during and after a transaction, and renders useless any credit card information a criminal may steal in a breach. Software development company Monkeetech last year announced a card fraud prevention system that requires the consumer to undergo an iris scan to prove their identity.
Full Article:
http://blogs.wsj.com/riskandcompliance/2014/01/28/retailers-try-to-keep-pace-with-cybercriminals/
"Coin vs.The Wocket A Battle for Your Bulging Wallet"
Americanlivewire.com - You may have heard something lately about something called Coin, thanks to an aggressive social media and deep intro discount pricing campaign currently underway. Perhaps you have heard of The Wocket, which claims to be a "biometrically secure device"? Both products are pure genius and aim to replace your bulging wallet with their single slick all-in-one card. Since they are so similar, here's a closer look and comparison of Coin vs. The Wocket, A Battle For Your Bulging Wallet.
Full article: http://americanlivewire.com/coin-vs-the-wocket/
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The   company  is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™, a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.   http://www.thewocket.com/
NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com /, http://3d-id.net/

MobileBio Wocket™

David Tunnell Bio:
David Tunnell is an expert in biometrics, secure communications, and wearable technologies.  With over 29 years of experience in building technologies and companies, Mr. Tunnell's experience spans computer security (COMSEC), signal intelligence (SIGINT), communications intelligence (COMINT), and image intelligence (IMINT).  An advocate of privacy and co-founder of NXT-ID, Inc., an early stage technology company, Mr. Tunnell is leading NXT's efforts to redefine how private information is protected within mobile applications.  As the chief architect of the Wocket™ smart wallet, Mr. Tunnell is focused on developing technologies with high potential to disrupt industries such as the mobile payment industry with innovative methods that protect privacy.
Mr. Tunnell's accomplishments include the Technology of the Year award from Frost & Sullivan for biometrics in 2006 and inventor of a Top Ten Invention for the US Army in 2004.  Blessed to work with some of the most inventive engineers and scientists, Mr. Tunnell has pioneered a number of technologies including remote distributed sensing and processing, 3D facial recognition and imaging, 3D fingerprint, voice recognition, dynamic biometric-enabled authentication and encryption key generation, and miniature, low-power wearable technologies.
Mr. Tunnell brings a wealth of product development and product marketing experience to NXT-ID, Inc.  He was the divisional director of 3D identification products at Technest Holdings Inc. from 2003 to 2012.  Prior to Technest, he served as an adjunct faculty teaching various advanced technology courses at the National Cryptologic School while working with various intelligence agencies and later at L3 Communications where he served as Director of Engineering for a subsidiary.  He has also served as the Principle Investigator for numerous research programs with the United States Department of Defense (DoD).  Mr. Tunnell holds a Masters in Technical Management (MSTM) from Johns Hopkins University and a BSEE from the University of Tennessee.
Contact Information
Contacts:
NXT-ID, Inc.
Corporate info: info@nxt-id.com , http://www.nxt-id.com/
Published at Investorideas.com
About www.InvestorIdeas.com : Big Ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors.
Research Biometrics Stocks at Investorideas.com stock directory
http://www.investorideas.com/BPS/Stock_List.asp
Sign up for free stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure: This email and content is for subscribers /investors at Investorideas and not for duplication and publication on other websites or blogs. If you would like to publish any content sent from investorideas email please send us a written request. Publication of our email alerts without written permission will be considered a violation of our copyright. The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights.  Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: November 2013: Investorideas is compensated by NXTD: five thousand per month for news publication and syndication and is long 144 shares from previous service. More info : http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country.
Become an Investorideas.com Member and access our 14 online stock directories 24/7 -mining stocks, oil and gas stocks and more...
http://www.investorideas.com/membership/
Any redistribution or publishing of information from our newsletter alerts and e-mails without the written consent of Investorideas.com is strictly forbidden 

Biometric Stock Alert: Get to Know The Wocket(TM), NXT-ID's (OTCQB: NXTD) Next Generation Biometrically Secure Smart Wallet; Consumer FAQ Released Prior to Launch

SHELTON, CT - February 7, 2014 (Investorideas.com Newswire) NXT-ID, Inc. (OTCQB: NXTD), a biometrics company focused on the growing m-commerce market, today announced the release of new product images and a consumer FAQ for Wocket™ which is set to launch this year. Wocket™ is a smart wallet much like the smart phone and smart watch. NXT-ID is introducing its innovative, patent-pending Wocket™ as the next natural step in the evolution of smart devices.

Answering consumer question number one, "Why buy a Wocket™? ", the FAQ tells us "Wocket™ replaces all the cards in your wallet. Wocket™ keeps all your information private while reducing the number of cards you have to carry with you. Wocket™ is smartest wallet you will ever own."
Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. Up to 10,000 cards, records, coupons, etc. and up to 100 voice commands can also be stored on Wocket™ and more can be supported with optional additional memory.
In terms of personal security, Wocket™ can assure consumers that private information cannot be accessed or stolen. A combination of voice biometrics, personal PIN or pattern provides multi-factor security for your Wocket™. Wocket™ protects whatever information is stored in it so that it cannot be released to any other individual or device without the user's permission.
Addressing competition in the digital wallet market, NXT-ID notes in the FAQ; "Rather than replace a wallet as many 'digital wallet' technologies attempt to do, we chose to improve the wallet. Unlike other digital wallet solutions that depend on connectivity to choose a payment account, Wocket™ does not depend upon the cloud to select or make a payment."
Other product feature announcements are pending as the Wocket™ launch rolls out but some of the unique features include:
1. Anti-tamper: Wocket™ contains certain anti-tamper components to protect certain secrets used within dynamic pairing authentication and encryption key generation. For instance, these probe-proof parts destroy themselves if probing is attempted as well as protect against man-in-the-middle and other type interrogations.
2. Custom categories: Private information is stored as "softcards" on the Wocket™. These softcards can be grouped via category names customized by the owner so that they are accessible very quickly via an organization method that best suits the owner of the data.
3. Voice cards: Although organization of softcards via user-customized categories enables users to find data faster, the fastest and simplest interface possible is to simply ask for the card. Our voicematch™ algorithm not only enables the user to ask for the softcard, but it also authenticates the owner of the information as he or she speaks.
4. Light Pipe: Wocket™ utilizes a new innovative light pipe technology to provide outstanding visibility even in the darkest environment.
5. Low-Power: Wocket's™ low power features include one of the lowest power touch interfaces and voice processing solutions in the world, providing long-lasting battery life.
6. No charge needed: Unlike many other devices that require a recharge, not only does the Wocket™ provide long battery life, but Wocket™ utilizes replaceable CR-2032 batteries commonly found at any retail store."
The full product FAQ is available to consumers and media at http://www.thewocket.com/ and http://www.wocketwallet.com/.
Interested consumers can also sign up for product info and news alerts in anticipation of the product launch.
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™, a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.thewocket.com/
NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
Contact:
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: November 2013 :Investorideas is compensated by NXTD: five thousand per month for news publication and syndication and is long 144 shares from previous services
More info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Frac Water Stock Alert: HII Technologies, Inc. (OTCBB/OTCQB: HIIT) Announces a Licensing Agreement for Frac Water Recycling System

HOUSTON - February 6, 2014 (Investorideas.com Newswire) HII Technologies, Inc. (the "Company"), symbol HIIT (OTCBB/OTCQB: HIIT), an oilfield services company focused on total frac water management, portable power and oilfield safety, headquartered in Houston, Texas, announced today that its wholly-owned subsidiary AES Water Solutions (AES), has licensed a high volume frac water recycling system to recycle flow back and produced water at the well sites during the completion process.

Currently, many horizontally drilled oil wells use up to 120,000 barrels (5 million gallon) of water to perform a hydraulic fracture in completing the oil or gas well, a frac operation. Of the water used, 20 to 30 percent is estimated to come back as flow back water within the first thirty days after the fracing operation. Today, in many cases these large quantities of flow back and produced water typically are transported by truck to an off-site facility for disposal. The transportation and disposal of flow back and produced water is a large expense item for exploration and production (E&P) companies and many local communities find the truck traffic unpopular.
AES is introducing its Frac Water Recycling System(TM) to address the need of onsite water reclamation for its E&P clients. This recycling system consists of a mobile unit that cleans up to 20,000 barrels-a-day of frac flow back water to acceptable reuse standards. The technology produces high volumes of polished brine or clear saltwater that is virtually free of total suspended solids (TSS) and is reusable in today's typical fracs in many cases cheaper than the cost to transport and disposal of the flow back water.
"The license granting the right to use this system is from Power Reserve Corp. (PRC), an existing corporate partner," said Mr. Brent Mulliniks, President of AES Water Solutions. "PRC procured the first system and licensed the related intellectual property and know-how required to operate the system, which in turn, has been sublicensed to AES Water Solutions," stated Mr. Mulliniks. He continued, "We expect this arrangement to enhance AES' overall services by offering a high volume recycling system for frac flow back and produced water for its customers. After testing, this water recycling unit is now field-ready and we anticipate entering into commercial agreements this month."
Mr. Mulliniks continued, "We believe this will set us apart from our competitors as we are not aware of another mobile onsite system on the market today that can treat over 20,000 barrels per day of water to these reuse standards which allows us to keep pace with the frac operations on a daily rate basis. Our total frac water management system includes water transfer, flow back services, above ground storage tanks, onsite recycling and wind-down pit evaporation."
About HII Technologies, Inc.
HII Technologies, Inc. is a Houston, Texas based oilfield services company with operations in Texas, Oklahoma, Ohio and West Virginia. By focusing on the Water, Power and Safety oilfield segments, the Company is positioned to take advantage of the anticipated, significant growth in horizontal drilling and hydraulic fracturing within the United States' active shale and unconventional "tight oil" plays. The Company's frac water supply and flow back services segment has two subsidiaries, AES Water Solutions and AquaTex, its onsite oilfield contract safety consultancy does business as AES Safety Services, and its mobile oilfield power subsidiary operates as South Texas Power (STP). HII Technologies' objective is to bring proven technologies to these operating divisions to build a long-term competitive advantage. Read more at www.HIITinc.com, www.AESwatersolutions.com, www.AquaTexUSA.com, www.AESSafetyServices.com and www.Oilfield-Generators.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements as to matters that are not of historic fact are forward-looking statements. These forward-looking statements are based on HII Technologies, Inc. ("HII")'s current expectations, estimates and projections about HII, its industry, its management's beliefs and certain assumptions made by management, and include statements regarding estimated capital expenditures, future operational and activity expectations, international growth, and anticipated financial performance in 2014. No assurance can be given that such expectations, estimates or projections will prove to have been correct. Whenever possible, these "forward-looking statements" are identified by words such as "expects," "believes," "anticipates" and similar phrases.
Readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict, including, but not limited to: risks that HII will be unable to achieve its financial, capital expenditure and operational projections, including quarterly and annual projections of revenue and/or operating income and risks that HII's expectations regarding future activity levels, customer demand, and pricing stability may not materialize (whether for HII as a whole or for geographic regions and/or business segments individually); risks that fundamentals in the U.S. oil and gas markets may not yield anticipated future growth in HII's businesses, or could further deteriorate or worsen from the recent market declines, and/or that HII could experience further unexpected declines in activity and demand for its hydraulic frac related water transfer business, its safety consultancy business or its generator and related equipment rental service businesses; risks relating to HII's ability to implement technological developments and enhancements; risks relating to compliance with environmental, health and safety laws and regulations, as well as actions by governmental and regulatory authorities. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Other important risk factors that may affect HII's business, results of operations and financial position are discussed in its most recently filed Annual Report on Form 10-K, recent Quarterly Reports on Form 10-Q, recent Current Reports on Form 8-K and in other Securities and Exchange Commission filings. Unless otherwise required by law, HII also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made here. However, readers should review carefully reports and documents that HII files periodically with the Securities and Exchange Commission.
Contact:
Investor Relations, HII Technologies +1-713-821-3157.
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers.
More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
HIIT disclosure: March 2013: two thousand per month for profile and news publication, renewed August 2013: five hundred per month for news publication
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Biotech News Alert: SUNSHINE BIOPHARMA (OTCQB: SBFM) CONTINUES ITS EFFORTS TO RE-DOMICILE IN CANADA FOR BUSINESS EXPANSION AND FINANCING OPPORTUNITIES FOR Adva-27a CANCER DRUG CANDIDATE

Montreal, Quebec, Canada - February 4, 2014 (Investorideas.com Biotech Newswire) Biopharma alert: Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of proprietary drugs for the treatment of various forms of cancer, today announced that it is continuing its efforts to re-domiciling the Company in Canada in order to capitalize on management’s belief that by doing so, the Company will generate additional business expansion opportunities and gain access to financing programs available to Canadian corporations. On January 31, 2014, the Company filed an S-4 Registration Statement wherein it is attempting to re-domicile to Canada from Colorado.

"We are very pleased with the progress we have made thus far in our efforts to re-domicile the Company in Canada," said Dr. Steve N. Slilaty, Chief Executive Officer of Sunshine Biopharma. "We are anxious to complete the re-domiciling process as we have attendant growth and financing opportunities that we believe are available to us once we have completed this action. This is important for the Company’s business strategy overall and for our Adva-27a anticancer drug candidate as we advance towards clinical trials for multidrug resistant breast cancer and pancreatic cancer."
About Adva-27a
Adva-27a is Sunshine Biopharma's lead anticancer compound, a small molecule that has recently been shown to be effective at killing multidrug resistant breast cancer cells, small-cell lung cancer cells, uterine sarcoma cells and pancreatic cancer cells (Published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012). Adva-27a is currently in the IND-Enabling stage of development. The original U.S. patent covering Adva-27a was issued on August 7, 2012 under U.S. patent number 8,236,935.
About Sunshine Biopharma Inc.
Sunshine Biopharma is an early stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. Sunshine Biopharma recently announced that it has initiated IND-Enabling studies for its lead antitumor compound, Adva-27a, which is currently targeted for multidrug resistant cancer.
Safe Harbor Forward-Looking Statements
To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.
For Additional Information Contact:
Camille Sebaaly, CFO
Sunshine Biopharma Inc.
Direct Line: 514-814-0464
camille.sebaaly@sunshinebiopharma.com
www.sunshinebiopharma.com
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: SBFM has renewed effective December 3,2013 with Investorideas for six months of news publication and general public awareness of the company news and technologies and products in the biopharma markets ( one hundred thousand shares of 144 stock per 3 month period for a total of six months ) More disclaimer info: http://www.investorideas.com/About/Disclaimer.aspBC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.